OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001621443

Zynerba Pharmaceuticals, Inc.

Zynerba Pharmaceuticals, Inc. (CIK 0001621443, EIN 26-0389433) reported revenue of $86,000 for FY2018 (2018-01-01 to 2018-12-31) and net income of -$35.04 million (-$35,035,806) for FY2022 (2022-01-01 to 2022-12-31), as filed in its 10-K filed 2019-03-11 (accession 0001558370-19-001742) and its 10-K filed 2023-03-28 (accession 0001558370-23-004765).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001621443
EIN26-0389433
SIC industry code2834 Pharmaceutical Preparations
State or country of incorporationDE
Fiscal year endDecember 31
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
Olympus entity IDorg_4rfxc3g91y9gnszrr0dh0nr484
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$86,000FY20182018-01-01 to 2018-12-3110-K2019-03-110001558370-19-001742Revenues
Net income-$35,035,806FY20222022-01-01 to 2022-12-3110-K2023-03-280001558370-23-004765NetIncomeLoss
Total assets$55,520,894FY2022as of 2022-12-3110-K2023-03-280001558370-23-004765Assets
Total liabilities$9,292,137FY2022as of 2022-12-3110-K2023-03-280001558370-23-004765Liabilities
Stockholders' equity$46,228,757FY2022as of 2022-12-3110-K2023-03-280001558370-23-004765StockholdersEquity
Operating cash flow-$23,026,950FY20222022-01-01 to 2022-12-3110-K2023-03-280001558370-23-004765NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$0.82 per shareFY20222022-01-01 to 2022-12-3110-K2023-03-280001558370-23-004765EarningsPerShareDiluted
Shares outstanding53,352,487 sharesFY2022as of 2023-03-2210-K2023-03-280001558370-23-004765EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2013-2022, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20182018-01-01 to 2018-12-31$86,00010-K2019-03-110001558370-19-001742
RevenueFY20172017-01-01 to 2017-12-31$010-K2019-03-110001558370-19-001742
RevenueFY20162016-01-01 to 2016-12-31$7,25010-K2019-03-110001558370-19-001742
RevenueFY20152015-01-01 to 2015-12-31$278,90010-K2018-03-120001558370-18-001906
Net incomeFY20222022-01-01 to 2022-12-31-$35,035,80610-K2023-03-280001558370-23-004765
Net incomeFY20212021-01-01 to 2021-12-31-$37,309,02410-K2023-03-280001558370-23-004765
Net incomeFY20202020-01-01 to 2020-12-31-$51,336,83110-K2023-03-280001558370-23-004765
Net incomeFY20192019-01-01 to 2019-12-31-$32,943,58310-K2022-03-010001558370-22-002451
Net incomeFY20182018-01-01 to 2018-12-31-$39,911,17510-K2021-03-100001558370-21-002669
Net incomeFY20172017-01-01 to 2017-12-31-$32,012,30410-K2020-03-100001558370-20-002280
Net incomeFY20162016-01-01 to 2016-12-31-$23,388,50710-K2019-03-110001558370-19-001742
Net incomeFY20152015-01-01 to 2015-12-31-$12,551,35010-K2018-03-120001558370-18-001906

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2023-08-142023-06-300001558370-23-014705zyne-20230630x10q.htm
10-Q2023-05-152023-03-310001558370-23-009685zyne-20230331x10q.htm
10-K2023-03-282022-12-310001558370-23-004765zyne-20221231x10k.htm
10-Q2022-11-142022-09-300001558370-22-017583zyne-20220930x10q.htm
10-Q2022-08-102022-06-300001558370-22-012982zyne-20220630x10q.htm
10-Q2022-05-162022-03-310001558370-22-008853zyne-20220331x10q.htm
10-K2022-03-012021-12-310001558370-22-002451zyne-20211231x10k.htm
10-Q2021-11-152021-09-300001558370-21-015868zyne-20210930x10q.htm
10-Q2021-08-092021-06-300001558370-21-010876zyne-20210630x10q.htm
10-Q2021-05-122021-03-310001558370-21-006862zyne-20210331x10q.htm
10-K2021-03-102020-12-310001558370-21-002669zyne-20201231x10k.htm
10-Q2020-11-092020-09-300001558370-20-013247zyne-20200930x10q.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001621443published by the sourcedata.sec.gov/submissions/CIK0001621443.json2026-10-21
Employer Identification Number (EIN) · US-EIN26-0389433published by the sourcedata.sec.gov/submissions/CIK0001621443.json2026-10-21

Former names

NameFromTo
Zynerba Pharmeceuticals, Inc.2014-10-092015-06-30

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001621443.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001621443.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001621443" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001621443/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001621443/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1621443"}

On SEC EDGAR

About this data